Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Adolesc Health. 2020 Aug 11;68(3):488–496. doi: 10.1016/j.jadohealth.2020.06.041

Table 4.

Scenario set 3: simulated HIV epidemic outcomes among adolescent sexual minority males (ASMM) assuming pre-exposure prophylaxis (PrEP) adherence and retention averaged across the ATN113 study and relative improvements based on changes reported in EPIC

Scenarios Uptake Incidence (95% SI) NIA/100K
person-years
at risk (95% SI)
PIA (95% SI) PrEP coverage
among all sexually
active ASMM
(95% SI)
NNT (95% SI) Prevalence
among 18-year-old
ASMM after 10 years
(95% SI)
No PrEP NA 1,191 (1,090, 1,276) NA NA NA 5.8 (4.3, 7.6)
Control .1 1,148 (1,073, 1,253) 64 (−172, 263) 3.3 (−10.2, 13.5) 4.5 (4.4, 4.7) 52 (−339, 537) 5.2 (4, 6.3)
Intervention 1,118 (1,011, 1,215) 110 (−142, 369) 5.7 (−8.5, 18.8) 5.8 (5.6, 6.0) 111 (−453, 826) 5.2 (3.9, 6.5)
Control .25 1,079 (982, 1,175) 169 (−134, 426) 9.0 (−8.1, 22.2) 11.0 (10.8, 11.2) 93 (−181, 587) 5.2 (4, 6.4)
Intervention 1,024 (932, 1,116) 252 (20, 500) 13.7 (1.1, 25.9) 13.8 (13.6, 14.0) 109 (56,310) 4.7 (3.6, 5.7)
Control .5 965 (896, 1,047) 341 (52, 571) 18.6 (3.2, 29.2) 20.8 (20.5, 21.0) 95 (61, 248) 4.4 (3.2, 5.6)
Intervention 885 (814, 959) 461 (221, 688) 25.4 (13.5, 35.4) 25.4 (25.1, 25.7) 112 (75, 178) 3.9 (3, 5.1)
Control .75 883 (798, 966) 464 (240, 656) 25.6 (14.5, 34.9) 29.3 (29.1, 29.6) 97 (73, 150) 4.0 (2.9, 5.4)
Intervention 781 (681, 862) 619 (405, 830) 34.2 (23.7, 44.0) 35.0 (34.7, 35.3) 71 (56, 103) 3.4 (2.4, 4.5)
Control 1 803 (736, 890) 584 (355, 776) 32.3 (21.7, 40.3) 36.9 (36.6, 37.2) 94 (75, 145) 3.6 (2.6, 4.7)
Intervention 702 (636, 761) 736 (523, 924) 40.8 (32.2, 48.4) 42.8 (42.5, 43.1) 68 (54,91) 3.1 (2.1, 4.1)

NIA = number of infections averted; NNT = number needed to treat to avert a single infection; PIA = percent of infections averted; SI = simulation interval.